Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls.
Beukhof CM, Brabander T, van Nederveen FH, van Velthuysen MF, de Rijke YB, Hofland LJ, Franssen GJH, Fröberg LAC, Kam BLR, Visser WE, de Herder WW, Peeters RP.
Beukhof CM, et al. Among authors: brabander t.
BMC Cancer. 2019 Apr 5;19(1):325. doi: 10.1186/s12885-019-5540-5.
BMC Cancer. 2019.
PMID: 30953466
Free PMC article.